Officer Files Intent to Sell $661K in Rapport Therapeutics Shares, Continuing Recent Selling Pattern

summarizeSummary

An officer of Rapport Therapeutics, Krishnaswamy Yeleswaram, has filed a Form 144 indicating intent to sell 19,365 common shares valued at approximately $661,702. This follows a pattern of recent sales by the same insider.

check_boxKey Events

• Officer Files Intent to Sell Shares

  Krishnaswamy Yeleswaram, an officer of Rapport Therapeutics, filed a Form 144 to sell 19,365 common shares.

• Significant Proposed Sale Value

  The proposed sale is valued at approximately $661,702.

• Continuation of Selling Pattern

  This filing follows previous sales by the same officer, with over $333,000 in shares already sold in the past three months, indicating a consistent pattern of insider distribution.

auto_awesomeAnalysis

This Form 144 filing signals an officer's intent to sell a notable amount of company stock, valued at over $661,000. While this represents a small percentage of the company's overall market capitalization, it is a significant transaction for an individual insider. The filing also indicates that this officer has sold shares multiple times in the past three months, suggesting a continued pattern of distribution. Investors should note this ongoing insider selling, which could be interpreted as a move to monetize "Founders Shares" acquired earlier.